Association News Archives - Page 3 of 11

20 Oct 23

Welcome New Associate Members to HKAPI

We are delighted to announce the addition of two new associate members to the HKAPI community: AON Solutions Hong Kong Limited and Links Recruitment Limited.

13 Oct 23

Guangdong Innovation and Development of Pharmaceutical and Medical Device Forum

Ms Sabrina Chan, Senior Executive Director of HKAPI, represented the Association to be one of the panellists of the Forum.

06 Oct 23

HKAPI Career Talk at HKU: Nurturing Biopharmaceutical Aspirations

The HR Committee successfully hosted a career talk at the University of Hong Kong, themed 'Why Should You Explore a Bio-Pharmaceutical Career?'.

06 Oct 23

HKAPI 2023 Policy Address Recommendations Submission

We are pleased that the HKAPI has submitted the 2023 Policy Address Recommendations to the Hong Kong government.

19 Jul 23

Primary Healthcare Sharing Session held successfully

HKAPI hosted a successful Primary Healthcare Sharing Session on July 18, 2023. The event was attended by over 60 representatives from HKAPI member, affiliate member, and associate member.

13 Jul 23

Regulatory Intelligence Forum

The HKAPI Regulatory Working Group recently held a forum for its members to exchange views on regulatory intelligence. Around 60 members attended the event.

08 Jun 23

HKAPI Annual Dinner 2023 – Innovate, Integrate & Impact

The HKAPI Annual Dinner 2023 on June 7th, held under the theme of Innovate, Integrate & Impact, was the first annual dinner event since 2019 due to the COVID-19 pandemic

22 May 23

HKAPI Welcomes Four New Members

We are excited to share that the HKAPI has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.

19 May 23

Pfizer Renewed as HKAPI Full Member

HKAPI is pleased to announce that Pfizer has renewed as full member of the Association.

05 Apr 23

Appointment of New Board Members

HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).

Welcome New Associate Members to HKAPI

Guangdong Innovation and Development of Pharmaceutical and Medical Device Forum

HKAPI Career Talk at HKU: Nurturing Biopharmaceutical Aspirations

HKAPI 2023 Policy Address Recommendations Submission

Primary Healthcare Sharing Session held successfully

Regulatory Intelligence Forum

HKAPI Annual Dinner 2023 – Innovate, Integrate & Impact

HKAPI Welcomes Four New Members

Pfizer Renewed as HKAPI Full Member

Appointment of New Board Members

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use